Comprehensive Parkinson's Disease Care
This site is intended for registered participants of the Comprehensive Parkinson's Disease Care.
Welcome! Thank you for joining us.
This coursewill provide a comprehensive multidisciplinary approach to the management of Parkinson’s Disease. Topics will include diagnosis and initial management, management of advancing Parkinson’s, the future of treatment, cognitive changes, autonomic dysfunction, weight loss and exercise with Parkinson’s, the role of speech therapy, and deep brain stimulation. The course is designed to enhance the training of Parkinson's Disease care providers and was prepared and curated by Movement Disorders Fellowship-trained neurologists at UNMC and Nebraska Medicine.
Course Objectives
At the conclusion of this activity, the participants should be better able to:
- Identify early signs and symptoms of Parkinson’s Disease.
- Recognize the ongoing research focusing on disease modification strategies in PD.
- Describe the possible neuropsychiatric complications in PD.
- State the roles of physical and occupational therapy in PD and the importance of exercise.
- Explain non-motor complications of PD including autonomic dysfunction.
- Discuss the surgical and non-surgical management options of advanced PD.
- Discuss the identification and management of weight loss in PD.
- Identify the role of speech therapy in PD.
General Information
This course has been approved for .55 continuing education units (corresponding to 5.5 contact hours) by the APTA NE Continuing Education Committee.
UNO Thompson Alumni Center
6705 Dodge Street, Omaha, NE 68182
Directions
Complimentary parking is available in the UNO Thompson Alumni Center parking lot. Please print this parking permit and display it on your front dash. Failure to display this permit may result in citation issuance. The UNMC Center for Continuing Education is not liable for any parking ticket a participant may incur while attending the symposium.
- The Zoom link for the live stream will be sent via email. If you do not see this email in your Inbox, please check your junk email folder. If you still do not see the message, please send an email to Tori Greenlee.
- To join the course, sign in to Zoom using your first and last name.
- Once you are in the webinar, go to the chat box and type in your first and last name so your attendance may be recorded.
Read the UNMC CCE Disclosure Declaration Policy
Disclosures
The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.
FACULTY
The following have disclosed relevant financial relationships:
- Josue Avecillas-Chasin, MD, PhD
Consultant: Boston Scientific Corporation, Medtronic - Amy Hellman, MD, FAAN
Site-PI for Kinect-HD Study: Neurocrine
Investigational/off-label use of drugs disclosure: Atropine (Sialorrhea); Fludrocortisone, Pyridostigmine (Orthostatic Hypotension); Glycopyrrolate, Ipratropium nasal spray (Rhinorrhea) - Mara Seier, MD*
Principle Investigator: GE Healthcare, Jazz Pharmaceuticals, Lundbeck Inc., Ono Pharmaceuticals - Kiel Woodward, MD
Investigational/off-label use of drugs disclosure: Carbidopa/Levodopa (Apathy); Donepezil (Apathy, Parkinson's Disease, Dementia/Psychosis); Rivastigmine (Apathy, Parkinson's Disease, Psychosis)
The following faculty members have nothing to disclose:
- Anne Mahnke, MOT, OTR/L*
- Jennifer McKune, MPT*
- Erin Cameron-Smith, MD
- Miguel Situ-Kcomt, MD
- Natalie Smith, MA, CCC-SLP*
- Jenna Wuebker, MS, RD, LMNT
- Lindsey Yaw, MS, CCC-SLP
PLANNING COMMITTEE
The following planning committee members have nothing to disclose:
- Missy Edwards
- Tori Greenlee
- Josh Mischo
- Jacqueline Siebels, BSN, RN, NPD-BC
*Faculty and planning committee member
The following materials (in PDF) are available for download until May 21, 2024. No part of these materials may be reproduced without prior written permission.
- Diagnosis and Initial Steps in the Management of Parkinson’s Disease
Miguel Situ-Kcomt, MD - Medical Management of Advancing Parkinson’s Disease
Mara Seier, MD - Looking Forward: The Future of Treatment in Parkinson’s Disease
Erin Cameron-Smith, MD - Mood, Apathy and Cognitive Changes in Parkinson’s Disease
Kiel Woodward, MD - Autonomic Dysfunction in Parkinson’s Disease
Amy Hellman, MD, FAAN - Unintentional Weight Loss in Parkinson’s Disease
Jenna Wuebker, MS, RD, LMNT - Implementing High-Intensity Exercise in Parkinson’s Disease Anne Mahnke, MOT, OTR/L and Jennifer McKune, MPT
- Role of Speech Therapy in Parkinson’s Disease
Natalie Smith, MA, CCC-SLP and Lindsey Yaw, MS, CCC-SLP - Deep Brain Stimulation for Parkinson’s Disease
Josue Avecillas-Chasin, MD, PhD
Requirements for Successful Completion
In order to receive continuing education credits, you must:
- Check in and attend the live activity.
- In-person: Check in at the registration desk.
- Live stream: Type in your first and last name in the Zoom chat.
- Complete the online evaluation via the UNMC MyCCE portal.
- On your dashboard, click Evaluate an Activity.
- Enter Activity Code 61869.
You have until May 21, 2024, to claim credit for this activity. You will need to complete the evaluation and attest to the time you spent participating in the activity. Your certificate will be saved in your UNMC MyCCE account under Certificates & Transcripts.
Need help managing your MyCCE account? Find answers to commonly asked questions about signing in to the portal, completing the online evaluation, retrieving your certificate, and more. Go to Manage MyCCE Account
Course Director
Assistant Professor and Division Chief, Movement Disorders, Department of Neurological Sciences, UNMC
Questions?
Educational Projects Coordinator
UNMC Center for Continuing Education
